BCMA-Directed Therapies (preclinical, clinical): B-cell maturation antigen (BCMA), a transmembrane glycoprotein crucial to plasma cell development, is significantly expressed in PBL, mirroring its expression in MM [75]. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.